“两票制”改革背景下医药第三方物流完善建议  

Optimization of the third-party logistics under the “two-invoice system” in China

作　　者：苏丽文[1] 柳鹏程[1] 

机构地区：[1]中国药科大学国际医药商学院,南京211198

出　　处：《上海医药》2017年第15期61-64,共4页Shanghai Medical & Pharmaceutical Journal

基　　金：中央高校基本科研业务费基金(项目编号:2016RPY004)

摘　　要：目的:通过对医药第三方物流企业配送效率进行研究,为两票制推行后保证药品的可及性提供建议。方法:采用委托代理模型,研究了影响物流效率的若干个因素,并将模型变量与医药物流实际因素结合,得出基于行业特点的政策建议。结果 :第三方物流公司应与流通公司确立一个适合的风险分担值,且引入外部可观测变量(信息系统、飞检结果公开等)能减少代理的风险。结论 :通过增强信息透明度、增加市场化程度、引入第三方监管,可以进一步披露企业努力程度,增加医药第三方物流企业的配送效率。Objective： To provide a proposal for ensuring the availability of drugs after the implementation of the two- invoice system by the study on the distributive efficiency of pharmaceutical third-party logistics enterprises. Methods： Several factors influencing the logistics efficiency were studied by using the principal-agent model in game theory, and the policy suggestions based on the characteristics of the industry were proposed by the model variables combined with the actual factors of pharmaceutical logistics. Results： The third-party logistics companies should establish a suitable risk-sharing value with the circulation company, and the introduction of external observable variables can reduce the risk of agents. Conclusion： The extent of business efforts can be further disclosed by enhancing the transparency of information, increasing the degree of marketization and introducing the third-party supervision so as to increase the distributive efficiency of the third-party logistics business.

关 键 词：两票制 委托代理 药品流通 第三方物流 

分 类 号：F259.23[经济管理—国民经济] F426.72[医药卫生—药学] R95